PROIETTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 587
EU - Europa 498
AS - Asia 77
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.164
Nazione #
US - Stati Uniti d'America 586
IE - Irlanda 130
IT - Italia 103
SE - Svezia 69
UA - Ucraina 64
HK - Hong Kong 42
FI - Finlandia 29
RU - Federazione Russa 25
DE - Germania 24
NL - Olanda 20
CN - Cina 18
GB - Regno Unito 14
FR - Francia 9
KR - Corea 5
SG - Singapore 4
CH - Svizzera 3
IN - India 3
LB - Libano 3
AT - Austria 2
GR - Grecia 2
IR - Iran 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
EU - Europa 1
PL - Polonia 1
Totale 1.164
Città #
Chandler 153
Dublin 130
San Mateo 72
Hong Kong 42
Altamura 38
Medford 28
Princeton 28
Wilmington 26
Lawrence 25
Perugia 24
Ann Arbor 23
Beijing 18
Des Moines 18
Andover 15
Saint Petersburg 12
Falls Church 11
Mondolfo 10
Boardman 7
Ashburn 6
Jacksonville 4
Redwood City 4
Singapore 4
Florence 3
Lausanne 3
Marino 3
San Paolo di Civitate 3
Woodbridge 3
Helsinki 2
Mcallen 2
Moscow 2
Norwalk 2
Ponte 2
Rome 2
Brussels 1
Buffalo 1
Centro 1
Crespino 1
Fairport 1
Frankfurt am Main 1
Houston 1
Lonigo 1
Los Angeles 1
Ottawa 1
Paris 1
Philadelphia 1
Portland 1
Praia A Mare 1
Prato 1
Sydney 1
Vienna 1
Totale 742
Nome #
The efficacy and safety of a multimodal therapy for chronic prostatitis/chronic pelvic pain: a prospective randomized study 95
IncobotulinumtoxinA in the treatment of neurogenic detrusor overactivity. 76
“Efficacy and tolerability of fesoterodine fumarate in the treatment of overactive bladder symptoms in patients affected by Multiple Sclerosis: Long term follow up”. 65
Clinical and urodynamic efficacy of Xeomin in the treatment of neurogenic detrusor overactivity: preliminary results. 63
Botulinum Toxin A Modulates Afferent Fibers in Neurogenic Detrusor Overactivity 62
OnabotulinumtoxinA intravesical treatment in patients affected by overactive bladder syndrome: best practice in real-life management 61
Botulinum toxin Type-A activity in prostate cancer 52
Desmopressin in the treatment of nocturia in patients affected by neurogenic bladder 51
Botulinum toxin a enters normal human urothelial cells and modulates the sensory activity of bladder urothelium 50
Vesical urothelium and new concepts 46
Overactive bladder and sexual function: a nightmare couple 46
OnabotulinumtoxinA intradetrusorial injections modulates bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 44
Single-session Supine Bilateral Percutaneous Nephrolithotomy 42
Normal human urothelial cell lines express onabotulinumtoxinA SV2 high affinity receptors. 39
OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: preliminary results 39
ONABOTULINUM TOXIN A INTRADETRUSORIAL INJECTION MODALITY: SHALL WE TAKE A REST? 38
TRATTAMENTO RIPETUTO CON MULTIPLE INFILTRAZIONI INTRADETRUSORIALI DI ONABOTULINUMTOSSINA A IN PAZIENTI AFFETTI DA VESCICA IPERATTIVA REFRATTARIA: RISULTATI A LUNGO TERMINE. 35
Contemporary management of the painful bladder: a systematic review. 34
Desmopressin in the treatment of nocturia in patients affected by Parkinson's disease 34
Is retrograde intrarenal surgery for the treatment of renal stones with diameters exceeding 2 cm still a hazard? 34
Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity 33
Cystoman® and calculi: a good alternative to standard therapies in preventing stone recurrence. 31
Chronic prostatitis: How to give our best without apposite vagueness 31
Six-year follow-up of intradetrusorial injections of botulinum toxin type a in patients with refractory neurogenic detrusor overactivity: Clinical and urodynamic results 30
Urinary symptoms and sexual dysfunction in patients affected by multiple sclerosis 24
Reply to Claus Riedl's Letter to the Editor re: Antonella Giannantoni, Vittorio Bini, Roger Dmochowski, et al. Contemporary Management of the Painful Bladder: A Systematic Review. 23
Resonance(A (R)) metallic stent in patients with ureterocutaneostomies 21
Overactive bladder 21
Totale 1.220
Categoria #
all - tutte 4.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/202090 2 12 7 2 3 1 31 4 17 5 5 1
2020/2021146 2 11 8 12 58 15 4 1 17 8 7 3
2021/2022221 5 49 0 10 6 7 1 70 5 4 22 42
2022/2023481 31 99 9 45 32 53 0 15 166 2 18 11
2023/202493 14 18 8 2 0 1 44 0 0 3 3 0
Totale 1.220